Work

5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice

Year: 2010

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.110.167890

Authors: Marcelo J.A. Amar, Wilissa D'Souza, Scott Turner, Stephen Demosky, Denis Sviridov, John Stonik, Jayraz Luchoomun, Jason Voogt, Marc Hellerstein, Dmitri Sviridov, Alan T. Remaley

Institutions: National Institutes of Health, National Heart, Lung, and Blood Institute, Baker Heart and Diabetes Institute, KineMed (United States), San Francisco General Hospital, University of California, San Francisco, University of California San Francisco Medical Center

Language: English

Topic: Cholesterol and Lipid Metabolism

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, Medical Research Council, National Health and Medical Research Council, National Heart, Lung, and Blood Institute

Awards: Treatment of atherosclerosis with the use of apolipoprotein A-1 mimetic peptides, Cholesterol Metabolism: a Focal Point in Pathogenesis of Atherosclerosis and Metabolic Diseases, from Cells to Patients

OpenAlex ID: W2119870307

FWCI: 9.379

Cites: 40

Cited by: 114

Related to: 10